A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car

Clinical Therapeutics

Volumn 25, Issue 5, 2003, Pages 1518-1538

  Ridout, Fran ^a   Shamsi, Ziba ^a   Meadows, Robert ^a   Johnson, Sigurd ^a   Hindmarch, Ian ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Antihistamines; Car driving; Cognitive function; Fexotenadine; Hydroxyzine

Indexed keywords

ALCOHOL; FEXOFENADINE; HYDROXYZINE; PLACEBO;

ADULT; ALCOHOL BLOOD LEVEL; ARTICLE; BODY WEIGHT; CAR DRIVING; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL FLICKER FUSION; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; EMOTION; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR RECOGNITION; NORMAL HUMAN; PSYCHOMETRY; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; RESPONSE TIME; SEDATION; TRAFFIC ACCIDENT; VALIDATION PROCESS;

EID: 0037945443     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(03)80137-6     Document Type: Article

References (43)

1. 1-receptor antagonists). Clin Exp Allergy. 1993;29(Suppl 3):125-132.
2. 1-antagonist, loratadine. Eur J Clin Pharmacol. 1987;32:419-421.
3. Ramaekers JG, Uiterwijk MM, O'Hanlon JF. Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. Eur J Clin Pharmacol. 1992;42:363-369.
4. Hindmarch I. CNS effects of antihistamines: Is there a third generation of non-sedative drugs? Clin Exp Allergy Rev. 2002;2:26-31.
5. Weiler JM, Bloomfield JR, Woodworth GG, et al. Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med. 2000;132:354-363.
6. Richards S, Thornhill D, Roberts H, Harries U. How many people think they have hay fever, and what they do about it. Br J Gen Pract. 1992;42:284-286.
7. Meltzer EO. Performance effects of antihistamines. J Allergy Clin Immunol. 1990;86:613-619.
8. Casale TB, Andrade C, Qu R. Safety and efficacy of once-daily fexofenadine HCl in the treatment of autumn seasonal allergic rhinitis. Allergy Asthma Proc. 1999;20:193-198.
9. Nelson HS, Reynolds R, Mason J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immtmol. 2000;84:517-522.
10. Finn AF Jr, Kaplan AP, Fretwell R, et al. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999;104:1071-1078.
11. Howarth PH, Stern MA, Roi L, et al. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. J Allergy Clin Immunol. 1999;104:927-933.
12. Van Cauwenberge P, Juniper EF, and the Star Study Investigating Group. Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis. Clin Exp Allergy. 2000;30:891-899.
13. Ciprandi G, Cosentino C, Milanese M, et al. Fexofenadine reduces nasal congestion in perennial allergic rhinitis. Allergy. 2001;56:1068-1070.
14. Craig-McFeely PM, Acharya NV, Shakir SA. Evaluation of the safety of fexofenadine from experience gained in general practice use in England in 1997. Eur J Clin Pharmacol. 2001;57:313-320.
15. Hindmarch I, Shamsi Z, Stanley N, Fairweather DB. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Br J Clin Pharmacol. 1999;48:200-206.
16. Nicholson AN, Stone BM, Turner C, Mills SL. Antihistamines and aircrew: Usefulness of fexofenadine. Aviat Space Environ Med. 2000;71:2-6.
17. Ridout F, Hindmarch I. No impairment of cognitive and psychomotor performance with fexofenadine in Japanese volunteers. Eur J Allergy Clin Immunol. 2002;57:237.
18. Vermeeren A, O'Hanlon JF. Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. J Allergy Clin Immunol. 1998;101:306-311.
19. Horne J, Reyner L. Vehicle accidents related to sleep: A review. Occup Environ Med. 1999;56:289-294.
20. Starmer G. Antihistamines and highway safety. Accid Anal Prev. 1985;17:311-317.
21. Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol. 2000;105:S622-S627.
22. Parkin CE, Kerr JS, Hindmarch I. The effects of practice on choice reaction time and critical flicker fusion threshold. Hum Psychopharmacol Clin Exp. 1997;12:65-70.
23. Sherwood N, Kerr JS. The reliability, validity and pharmacosensitivity of four psychomotor tests. In: Human Psychopharmacology: Measures and Methods. Hindmarch I, Stonier PD, eds. Chichester, NY: Wiley; 1993:67-91.
24. Hindmarch I, Subhan Z, Stoker MJ. The effects of zimeldine and amitriptyline on car driving and psychomotor performance. Acta Psychiatr Stand Suppl. 1983;308:141-146.
25. Woodworth RS, Schlosberg H. Experimental Psychology. London: Methuen; 1958:380-403.
26. Ridout F, Hindmarch I. Effects of tianeptine and mianserin on car driving skills. Psychopharmacology (Berl). 2001;154:356-361.
27. Hindmarch I, Gudgeon AC. The effects of clobazam and lorazepam on aspects of psychomotor performance and car handling ability. Br J Clin Pharmacol. 1980;10:145-150.
28. Hindmarch I, Shamsi Z, Kimber S. An evaluation of the effects of high-dose fexofenadine on the central nervous system: A double-blind, placebo-controlled study in healthy volunteers. Clin Exp Allergy. 2002;32:133-139.
29. Gengo FM, Dabronzo J, Yurchak A, et al. The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine. Clin Pharmacol Ther. 1987;42:265-272.
30. Goetz DW, Jacobson JM, Murnane JE, et al. Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J Allergy Clin Immunol. 1989;84:316-322.
31. Maycock G. Drinking and Driving in Great Britain: A Review. Berkshire, England: TRL; 1997. Report 232.
32. Moriya F, Nanikawa R. Interactive effect of ethanol administration on blood hydroxyzine levels in rabbits. Arukoru Kenkyuto Yakubutsu Ison. 1990;25:441-448.
33. Simpson K, Jarvis B. Fexofenadine: A review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs. 2000;59:301-321.
34. Jick H, Hunter JR, Dinan BJ, et al. Sedating drugs and automobile accidents leading to hospitalization. Am J Public Health. 1981;71:1399-1400.
35. Mellen PF, Sohn SS. Military parachute mishap fatalities: A retrospective study. Aviat Space Environ Med. 1990;61:1149-1152.
36. Kay GG, Harris AG. Loratadine: A non-sedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clin Exp Allergy. 1999;29(Suppl 3):147-150.
37. Roberts DJ, Gispert J. The non-cardiac systemic side-effects of antihistamines: Ebastine. Clin Exp Allergy. 1999;29(Suppl 3):151-155.
38. Adelsberg BR. Sedation and performance issues in the treatment of allergic conditions. Arch Intern Med. 1997;157:494-500.
39. Haria M, Fitton A, Peters DH. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs. 1994;48:617-637.
40. Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with "non-sedating" antihistamines: Four prescription-event monitoring studies in general practice. BMJ. 2000;320:1184-1186.
41. Shamsi Z, Hindmarch I. Sedation and antihistamines: A review of inter-drug differences using proportional impairment ratios. Hum Psychopharmacol. 2000;15(Suppl 1):S3-S30.
42. Dogan AS, Catafau AM, Zhou Y. In vivo cerebral histamine receptor occupancy of three antihistamine drags: A 11C-doxepin PET study. Eur J Nucl Med. 2001;28:OS52. Abstract.
43. Tashiro M, Sakurada Y, Mochizuki H, et al. Study on CNS side effects of fexofenadine and cetirizine: Measurement of histamine H1 receptor occupancy using positron emission tomography J Clin Pharmacol. 2002;42:88. Abstract.